LABORATORIOS FARMACEUTICOS ROVI, S.A.
Headquarters address: C/ Julián Camarillo, 35, 28037 Madrid
CIF A28041283 Spain Chemical industry Pharmaceutical seen 1427 times Last report December 2020
Employees | 516 (56.80% women) |
Profit | 61.06M € |
Indebtedness | 53.72% |
Income | 420M € |
Earnings per share | 1.09 € |
Solvency | 286.2% | 0.81% |
Short solvency | 111.8% | 7.85% |
Working balance on income | 57.55% | -5.27% |
Working balance on assets | 66.29% | -2.88% |
Non current assets coverage | 178.1% | -2.75% |
Fixed assets on long term debt | 480% | 9.06% |
Cash on Current Assets | 14.58% | 44.66% |
Inmovilization | 36.53% | 3.28% |
Cash on Current Liabilities | 43.26% | 36.22% |
Leverage | 12.8% | -7.64% |
Debt Quality | 38.78% | -7.16% |
Financial Expenses Coverage | 6.97K% | 59.32% |
Short term Indebtedness | 32.88% | 3.83% |
Long term Indebtedness | 20.83% | -8.31% |
Financial Expenses on EBIT | 1.44% | -37.23% |
Indebtedness Ratio | 34.95% | -0.81% |
Indebtedness on EBIT | 268.8% | -18.65% |
Assets Turnover | 73.11% | 0.68% |
Customers Turnover | -549.7% | 6.25% |
Fixed Assets Turnover | 200.1% | -2.52% |
Suppliers Turnover | 214.9% | 8.08% |
Profit on Income/Sales | 14.54% | 8.94% |
Earnings per share | 1.09 € | 15.96% |
Funds from Operations | 80.65M € | 12.41% |
EBIT Margin | 17.78% | 21.12% |
Operating Margin | 17.28% | 19.2% |
ROA | 10.63% | 9.67% |
ROE | 16.34% | 9.2% |
Profitability | 9.45% | 25.52% |
Economic Profitability | 13% | 21.94% |
Rea Estate Profitability | -188.5% | -16.34% |
Expenses/Profit | 99.66% | -20.09% |
EBIT | -6.97K% | 59.32% |
Staff expenses | 144.2K € | 2.73% |
Financial Expenses on Sales | 0.26% | -23.98% |
Cash Flow per share | -254.6K | -54.31% |
Cash Flow on assets | -2.48% | -56.79% |
Cash Flow on income/sales | -3.4% | -57.08% |
Dividends on Cash Flow | 0% | 0% |
Cash Flow Margin Ratio | 11.16% | -265.3% |
Cash Flow on short-term Liabilities | 11.61% | -58.57% |
Cash Flow on long-term Liabilities | 18.32% | -53.08% |
Cash Flow on Debt | 19.4% | -53.22% |
External Financing | 150.8% | -322.9% |